The role of incretin hormones and glucagon in patients with liver disease

被引：1
|
作者：
Junker, Anders Ellekaer [1 ]
机构：
[1] Gentofte Univ Hosp, Ctr Diabet Res, Kildegardsvej 28, DK-2900 Hellerup, Denmark
来源：
DANISH MEDICAL JOURNAL | 2017年 / 64卷 / 05期
关键词：
GASTRIC-INHIBITORY POLYPEPTIDE; DEPENDENT INSULINOTROPIC POLYPEPTIDE; TYPE-2; DIABETES-MELLITUS; GLUCOSE-TOLERANCE TEST; PEPTIDE-1; 7-36; AMIDE; BETA-CELL FUNCTION; FATTY LIVER; HEPATIC STEATOSIS; ORAL GLUCOSE; FASTING HYPERGLUCAGONEMIA;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：13
相关论文
共 50 条
  • [21] Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
    Kanasaki, Keizo
    Kawakita, Emi
    Koya, Daisuke
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [22] Regional Variation in Expression of Enzymes That Synthesise Incretin Hormones and Glucagon in Lean and Morbidly Obese Humans
    Claridge, Laura E.
    Valiyapurayil, Neha V.
    Nguyen, Nam Q.
    Rayner, Christopher K.
    Wu, Tongzhi
    Burgess, Jenna E.
    Pezos, Nektaria
    Young, Richard L.
    DIABETES, 2015, 64 : A528 - A529
  • [23] Effects of MEDI0382, a glucagon-like peptide 1/glucagon receptor dual agonist, on pancreatic and incretin hormones
    Jermutus, L.
    Tsai, L. -F.
    Robertson, D.
    Petrone, M.
    Rondinone, C.
    Boaz, H.
    Ambery, P.
    Parker, V.
    DIABETOLOGIA, 2018, 61 : S382 - S382
  • [24] Control of liver glucokinase activity: A potential new target for incretin hormones?
    Francini, Flavio
    Laura Massa, Maria
    Patricia Polo, Monica
    Villagarcia, Hernan
    Cecilia Castro, Maria
    Jose Gagliardino, Juan
    PEPTIDES, 2015, 74 : 57 - 63
  • [25] The effects of incretin hormones on cerebral glucose metabolism in health and disease
    Nilsson, Malin
    Gjedde, Albert
    Brock, Birgitte
    Gejl, Michael
    Rungby, Jorgen
    NEUROPHARMACOLOGY, 2018, 136 : 243 - 250
  • [26] ELIMINATION AND DEGRADATION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PATIENTS WITH END-STAGE RENAL DISEASE
    Idorn, Thomas
    Knop, Filip K.
    Jorgensen, Morten B.
    Christensen, Mikkel
    Holst, Jens J.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 422 - 422
  • [27] METABOLIC ACTIONS OF GLUCAGON-FAMILY HORMONES IN LIVER
    MOMMSEN, TP
    MOON, TW
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 1989, 7 (1-6) : 279 - 288
  • [28] Incretin-based therapies for liver disease
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (08) : 533 - 533
  • [29] ROLE OF LIVER IN GLUCAGON METABOLISM
    JASPAN, JB
    HUEN, AHJ
    MORLEY, CG
    MOOSSA, AR
    RUBENSTEIN, AH
    JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (02): : 421 - 428
  • [30] HORMONES AND LIVER DISEASE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1958, 1 (FEB1): : 270 - 272
12345